RWD129 A Comparison of ICU Admission Rate and Related Cost Among Patients Taking Nirmatrelvir and Ritonavir Combination Versus Molnupiravir for Treatment of Mild to Moderate COVID-19 in the US
Abstract
Authors
I Kukreja A Gaur N Upadhyay S Bhalani A Gupta V Verma S Pandey A Roy A Nayyar S Daral S Chawla P Mohanty